glp-1 options for type 2 diabetes and obesity 2025 Orforglipron, approved as Foundayo on April 1, 2026, adds another oral option chronic weight management in adults with or overweight plus at least one weight-related condition. The clinical relevance How Supply and Demand for

The LIPOSHELL technology helps ensure vitamin C is protected from substances within the body's digestive system which may degrade the active ingredient and reduce absorption

Appetite For many people, appetite changes are usually the first signs to appear

Mayo Clinic announced 18 AI HealthTech startups for cohort 7 of its Platform Accelerate program, bringing the total to 76 AI startups since 2022

Wu, G., Fang, YZ, Yang, S., Lupton, JR, & Turner, ND (2004)

Five studies could not be included in the quantitative synthesis because they did not report depressive-symptom outcomes with the summary statistics needed to calculate the effect size